Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $38.08 USD
Change Today +0.70 / 1.87%
Volume 78.2K
OFIX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John Michael Egan

AgeTotal Calculated CompensationThis person is connected to 29 board members in 5 different organizations across 6 different industries.

See Board Relationships
67--

Background*

Mr. John Michael Egan has been President and Chief Executive Officer of Bluebird Development, LLC since 1996 and a financial partnership with Osaka, Japan-based Kobayashi Pharmaceutical Company, a major distributor of medical devices in Asia. Since 1992, Mr. Egan has been involved in venture capital investing in early stage medical device companies. From 1992 to 1996, Mr. Egan was a partner in Sanderling Ventures, a Menlo Park based biomedical seed-stage venture firm. ...

Read Full Background

Corporate Headquarters*

7 Abraham de Veerstraat
Willemstad, -- --

Curaçao

Phone: 599 9 465 8525
Fax: 599 9 461 6978

Board Members Memberships*

Board Member
2003-Present
Director and Member of Compensation and Personnel Committee
2004-Present
Director and Chairman of Audit Committee
2010-Present
Independent Director, Member of Audit Committee and Member of Nominating Committee

Education*

BA
Colorado College
BS
Boston College

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OFIX:US $38.08 USD +0.70

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey H. Burbank Founder, Chief Executive Officer and Director
Nxstage Medical, Inc.
$496.9K
Brian K. Hutchison Chief Executive Officer, President and Director
RTI Surgical Inc.
$550.0K
Fred P. Lampropoulos Chairman of The Board, Chief Executive Officer and President
Merit Medical Systems, Inc.
$1.1M
Joseph M. Devivo Chief Executive Officer, President and Director
AngioDynamics Inc.
$873.6K
David H. Mowry Chief Executive Officer, President and Executive Director
Tornier N.V.
$548.6K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ORTHOFIX INTERNATIONAL NV, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.